(Información remitida por la empresa firmante)
HUDDINGE, Sweden, Oct. 5, 2023 /PRNewswire/ -- XNK Therapeutics AB today announced that Anna-Karin Maltais, Chief Scientific Officer, will be speaking at the 2nd Annual Innate Killer Europe Summit in London on October 18.